SEC Filings for AstraZeneca Plc (AZNCF)

$ 96.85 0.00 (0.00%) Volume: 42 9:30 AM EST Feb 13, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934102/14/2020
3Initial statement of beneficial ownership of securities102/07/2020
4Statement of changes in beneficial ownership of securities102/07/2020
SC 13DGeneral statement of acquisition of beneficial ownership1102/07/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/05/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934102/03/2020
SC 13GStatement of acquisition of beneficial ownership by individuals701/30/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934101/27/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934101/27/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934101/27/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934101/27/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals701/27/2020
F-6Registration statement under the Securities Act of 1933 for depositary shares evidenced by American depositary receipts7301/22/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934101/21/2020
<<
First
<
Prev
123456789101112131415